Effect of using L_arginine in reducing the heart toxicity produced from use Doxorubicin anticancer drug on some hormones in the experimental male rabbits
Article Sidebar
Main Article Content
Abstract
This study amid to search the role of L_arginine in reducing the heart toxicity and atherosclerosis which result from using of Doxorubicin in treatment of cancer Also the role of hydrogen peroxide in inducing oxidative stress in Laboratory Albino rabbit as Growth Hormone and (T3,T4,TSH) levels, the Study included 40 male rabbits, where each group consist of 5 animals The results showed a high Significant decrease in Growth Hormone concentration (P≤0.01) in Dox group (15mg/kg of.w) and group of animals treated with H2O2 alone while the concentrations of GH had been increase with high significant (P≤0.01) in other groups. The results showed a high significant (P ≤ 0.01) in the hormone T4 concentration in serum in the group H2O2 and Dox group alone compare with control and the occurrence of a highly significant increase (P≤0.01)of Hormone T3,T4 concentrations in Animal group treated with Dox (15 mg/kg) and L-arginine Also group treated with H2O2 and L-arginine, and group treated with Cholesterol and L-arginine. while high significant decrease (P≤0.01) had been happened in Hormone (T3) (T4) concentration in sera of other groups of animals compared with the control. and found through the study and having High Significant decrease in TSH concentration (P≤0.01) in serum in the group treated with Dox and L-arginine, and group treated with Cholesterol and L-arginine compared with the control .there were no significant differences in the concentration of the hormone TSH in the group H2O2 alone while the concentrations of TSH had been increase with high significant (P≤0.01) in other groups.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1- Kenyon, N. J; Last, M; Bratt, J. M; Kwan, V. W;
O’Roark, E. and Linderholm, A. (2011). L-Arginine
Supplementation and Meta-bolism in Asthma.
Pharmaceuticals; 4: 187-201.
2- Fletcher, M; Ramirez, M. E; Sierra, R; Raber, P.
and Rodriguez, P. (2013). Modulation of T cell
function through L-arginine metabolism: a new
therapy from an old enemy. Journal for
ImmunoTherapy of Cancer; 1(1): 10.
3- Ogawa, T.; Higashi, S.; kawarada, Y.; and
Mizumoto, R.(1995). Role of reactive oxygen in
synthetic estrogen induction of hepatocellular
carcinomas in rats and Preventive effect of Vitamins .
Carcinogenesis , 16 : 831-836 .
4- Ottonello, S.; Foroni, C.; Carta, A.; Petrucco,
S.;and Maraini, G.(2000). Oxidative stress and agerelated
cataract .Ophthalmology. 214: 78-85 .
5- Wendland, B.; Aghdassi, E.; Tam C.; Carrier, J.;
Steinhart, A.; Wolman, S.; Baron, D. and Allard, J.
(2001). Lipid peroxidation and plasma antioxidant
micronutrients in crohndisease. Am. J. Clin. Nutr.,
74:259-264.
6- Craig, C. and Stitzel, R. (1982) Modern
Pharmacology, (1sted) Ch56 745-789,http:/www.link.
Sparinger. de/search.htm.
7- Kojima M, Hosoda H, Date Y,.(1999) Ghrelin is a
growth-hormone-releasing acylated peptide from
stomach. Nature;402:656-660.
8- Eaton, J. and Qian, M.( 2002). Free Rad. Biol.
Med, 32, 833-840.
9- Yagmurca M, Bas O, Mollaoglu H, Sahin O, Nacar
A, Karaman O, Songur A (2007) Protective effects of
erdosteine on doxorubicin – induced hepatotoxicity in
rats .Arch Med Res ,38(4):380-385,.
10- Han D, Loukianoff S, McLaughlin L (2010).
Oxidative stress indices: analytical aspects and
significance. In: Sen CK, Packer L, Hanninen O (eds)
Handbook of oxidants and antioxidants in exercise.
Elsevier, New York, pp 43 3-484 .
11- Flynn, N. E., Meininger, C. J., Haynes, T. E. and
Wu, G. (2002). The metabolic basis of arginine
nutrition andpharmacotherapy. Biomedicine &
Pharma cotherapy; 56: 427-438.
12- Eaton, J. and Qian, M. (2002). Free Rad. Biol.
Med, 32, 833-840.
13- Yang, J., Zhang, R., Lu, G., Shen, Y., Peng, L.,
Zhu, C., Cui, M., Wang, W., Arnaboldi, P., Tang, M.,
Gupta, M., Qi, C. F., Jayaraman, P., Zhu, H., Jiang,
B., Chen, S. H., He, J. C., Ting, A. T., Zhou, M. M.,
Kuchroo, V. K., Morse, H. C., Ozato, K., Sikora, A.
G. and Xiong, H. (2013). T cell-derived inducible
nitric oxide synthase switches off TH17 cell
differentiation. J. Exp. Med; 210: 1447-1462.
14- Rudling, M.; Oarini, P. &Angelin, B. (1997).
Growth hormone and bile acid synthesis.Keyrole for
the activity of hepatic microsoma cholesterol 7ahydroxylase
in the rot. J. Clin. Invest., 99:2239-2245.
15- Kedari, G. S. R. (2011). Evaluation of the
Thyroid Status, Oxidant Stress and Antioxidant
Status in patients with Type - 2 Diabetes Mellitus.
India Journal of Clinical and Diagnostic Research.
Vol- 5(2):254- 256 -255.
16- Woeber, K. A.(2000). Update on the management
of hyperthyroidism and hypothyroidism. Arch Fam
Med; 9: 43 - 747 .
17- Asvold, B.O.; Vatten, L.J.; Nilsen, T.I.L.; Bjoro,
T. (2007).The association between TSH within the
reference range and serum lipid concentrations in a
population-based study.Euro. J. Endocr., 156, 181-
186.
18- Zhu, X.; Cheng, S.Y. (2010).New insights into
regulation of lipid metabolism by thyroidhormone.
Curr. Opin. Endocrinol. Diabetes Obes.,17 (5), 408-
413.
19- Kopple J, Ding H, and Letoha A (2002). Lcarnitine
ameliorates gentamicin-induced renal injury
in rats. Nephrol. Dial. Transplant., 17: 2122–2131.
20- Padwal, R.; Straus, S.H.; McAlister, F. (2001).
Cardiovascular risk factors and their effectson the
decision to treat hypertension: evidence based review
.BMJ.,322, 977-980.
21- Al-Rubae'i, S.H. N. and Al-Musawi, A.K. (2011).
An evaluation of antioxidants and oxidative stress in
Iraqi patients with thyroid gland dysfunction. African
Journal of Biochemistry Research Vol . 5(7), pp. 188-
196.
22- Patidar, R.K.; Raghuwanshi, R.; Sharma, P.;
Singh, V.(2012). An associative investigationbetween
TSH and serum lipid concentrations in the population
of Bhopal, India. IJPSR., 3 (4),1112-1115.
23- Chandra, A.K., mukhopadyay, S., Lahari,D. and
Tripathy, S.(2004).Giotrogenic content of Indian
cyanogenic plant foods and their in vitro anti–
thyroidal activity. Indian J. Med Res; 119 : 180–185.
24- Abdelatif, A. M. and Saeed, I. H.(2009). Effect of
Altered Thyroid Status in the Domestic Rabbit
(Lepuscuniculus) on Thermoregulation, Heart Rate
and Immune Responses.Department of Physiology,
Faculty of Veterinary Medicine,University of
Khartoum, Sudan, P.O. Box 32,Khartoum North,
Sudan Department of Physiology, College of
Veterinary Science, University of Bahr El-Ghazal,
Sudan. Global , Veterinaria 3 (6): 447-456.
25- Meier, C., Staub, J., Roth, C., Guglielmetti, M.,
Kunz, M., Miserez, A. R., Drewe, J., Huber, P.,
Herzog, R., and Müller, B. (2001) TSH-Controlled LThyroxine
Therapy Reduces Cholesterol Levels and
Clinical Symptoms in Subclinical Hypothyroidism: A
Double Blind, Placebo-Controlled Trial (Basel
Thyroid Study). The Journal of Clinical
Endocrinology & Metabolism Vol. 86, No. 10 4860-
4866.
26- Auer, J.; Berent, R.; Weber, T.; Lassing, E.; Eber,
B. (2003). Thyroid function is associated with
presence and severity of coronary atherosclerosis.
Clin.Cardiol.,26, 569-573.
27- Peppa, M.; Betsi, G.; Dimitriadis, G. (2011).
Lipid abnormalities and cardiometabolic risk in
patients with overt and subclinical thyroid disease. J.
Lipids.,, 1-9.
28- Yun, K.H.; Jeong, M.H.; Oh, S.K.; Lee, E.M.;
Lee, J.; Rhee, S.J.; Yoo, N.J.; Kim, N.H.; Ahn, Y.K.;
Jeong, J.W. (2007). Relationship of thyroid
stimulating hormone withcoronary atherosclerosis in
angina patients. Int. J. Cardiol., 122 (1), 56-60.
29- Pistone G, Finocchiaro G, Dell-Arte S, Leotta C,
Marino A.(2003) Levocarnitine administration in
elderly subjects with rapid muscle fatigue: effect on
body composition, lipid profile and fatigue. Drugs
Aging; 20(10):761-767.